| INTRODUCTION
Gastroparesis presents with nausea, vomiting, early satiety, fullness, bloating, and pain with objective evidence of delayed gastric emptying. 1 The diagnosis of gastroparesis may be made by scintigraphy or by gastric emptying breath testing. [2] [3] [4] A third method, wireless motility capsule (WMC) testing, is approved to quantify gastric emptying in suspected gastroparesis by detecting pH increases as the capsule passes from the stomach to duodenum. 5 WMC gastric emptying times correlated well with scintigraphic emptying in a smaller prior report.
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Although presumed to originate in the stomach, gastroparesis symptoms are non-specific and may be reported with other lower functional gastrointestinal disorders. 6, 7 Gastroparesis patients also describe bowel disturbances suggesting involvement of multiple gut regions. 8, 9 WMC methods offer expanded capabilities over scintigraphy, providing small bowel and colon transit measurements in generalized motility disorders. [10] [11] [12] Retrospective WMC series have defined extragastric transit delays in some patients with presumed gastroparesis. 13, 14 The WMC pressure sensor estimates contractility in different gut regions. 15 Reduced gastric and colon contractions have been defined in small gastroparesis cohorts. 16, 17 However, abnormalities of transit and contractility in different gut regions have not been contrasted in patients with diabetic versus idiopathic gastroparesis.
The importance of gastric and extragastric transit and contractility abnormalities in causing gastroparesis symptoms is unproved.
Symptom severities measured using standardized questionnaires from a large registry of patients with such symptoms were not different in those with delayed versus normal gastric emptying measured by scintigraphy. 18 In that report, a novel patient subgroup with similar symptoms as gastroparesis but with normal emptying, termed chronic unexplained nausea and vomiting (CUNV), was defined. In one retrospective WMC assessment of patients with generalized dysmotility symptoms, upper and lower gut symptoms did not predict transit abnormalities. 12 However, duodenal contractility on WMC tests negatively correlated with overall symptom severity in another small gastroparesis cohort. 19 Drawbacks of older WMC studies in gastroparesis include their retrospective nature, small sample sizes, non-standardized gastric scintigraphy methods, and lack of symptom characterizations using validated surveys.
This investigation related prospective WMC data from a large, multicenter cohort from the NIDDK Gastroparesis Consortium to standardized gastric scintigraphy findings and gastrointestinal symptoms quantified by validated questionnaires. Specific aims were to:
(i) characterize WMC gastric and extragastric transit and contractility in suspected gastroparesis, including comparisons in diabetic versus idiopathic patients, (ii) associate gastric emptying delays measured by Rapid transit was rarely observed. Diabetics had slower GET but more rapid SBTT versus idiopathics (P ≤ .02). GET delays related to greater scintigraphic retention, slower SBTT, and fewer gastric contractions (P ≤ .04). Overall gastroparesis symptoms and nausea/vomiting, early satiety/fullness, bloating/distention, and upper abdominal pain subscores showed no relation to WMC transit. Upper and lower abdominal pain scores (P ≤ .03) were greater with increased colon contractions. Constipation correlated with slower CTT and higher colon contractions (P = .03). Diarrhea scores were higher with delayed SBTT and CTT (P ≤ .04).
Conclusions & Inferences:
Wireless motility capsules define gastric emptying delays similar but not identical to scintigraphy that are more severe in diabetics and relate to reduced gastric contractility. Extragastric transit delays occur in >40% with suspected gastroparesis. Gastroparesis symptoms show little association with WMC profiles, although lower symptoms relate to small bowel or colon abnormalities.
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Key Points
• Wireless motility capsule (WMC) findings in suspected gastroparesis and relations to symptoms have been poorly defined.
• Evaluation of patients with gastroparesis symptoms revealed gastric emptying delays with WMCs that were similar to scintigraphy, were related to reduced contractility, and were often associated with extragastric or generalized transit delays; symptoms correlated poorly with WMC profiles.
• These findings provide insight into motor abnormalities in gastroparesis pathogenesis and form a basis for future investigations studying the impact of WMC testing on clinical care.
WMC and scintigraphy with other transit and contractility measures in suspected gastroparesis and provide insight into CUNV pathogenesis, and (iii) relate symptom severity to WMC transit and contractility to ascribe potential pathogenic roles for motor dysfunction to symptom genesis. These analyses defined the breadth and pathophysiologic importance of motor abnormalities in suspected gastroparesis to form a foundation for future studies investigating the impact of WMC testing on decision making and outcomes. Some data within this study were presented at Digestive Disease Week in 2015 and 2016. In-DTPA (diethylenetriaminepentaacetic acid)-labeled water along with the solid meal. were instructed to keep the data receiver within 3 feet of their bodies at all times for the next 4-7 days until they returned the data receiver.
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| MATERIALS AND METHODS
| Patient populations
| WMC testing
Patients continued to abstain from proton pump inhibitors and medications that influence gut transit over this 4-to 7-day period.
Gastric emptying times (GET) were calculated from the time of WMC ingestion to when the capsule passed into the duodenum, as defined by abrupt ≥2 pH unit increases from the lowest postprandial value to levels ≥4 that persisted for at least 10 minutes. WMC ileocecal junction transit was detected when pH decreased ≥1.0 pH unit for at least 10 minutes ≥30 minutes after pyloric passage. WMC small bowel transit times (SBTT) were calculated from the end of the GET period to ileocecal junction passage. Anal WMC evacuation was detected by abrupt 0.025°C per second decreases in temperature. WMC colon transit times (CTT) were calculated from the end of the SBTT period to the time of anal capsule expulsion. WMC contractions >10 mmHg in amplitude were quantified in the hour before GET to measure gastric contractility while contractions in the hour after GET determined small bowel contractility as described previously. 13 Motility indices (MI) in the hour before (gastric) and after GET (small bowel) were calculated from the logarithmic transformation of the areas under the contraction curves. Numbers of contractions >25 mm Hg in amplitude per hour and MI were calculated for the entire period of colon transit using accepted methods. 24 Normal gastric emptying times (GET) (≤5 and >1:45 hours), small bowel transit times (SBTT) (≤6 and >2:15 hours), and colon transit times (CTT)(≤58:45 and >4:30 hours) were defined in a recent report. 23 Severely delayed GET (>12 hours) was defined as previously. 16 Numbers of contractions and motility indices (MI) for each region were calculated as measures of contractility. 16, 23 Numbers of gastric and small bowel contractions <29/hour and <36/hour and gastric and small bowel MI <9.82 and <10.57, respectively, have been defined as below the 5th percentile for normal volunteers. 16 Normal cutoffs for numbers of contractions and MI for the colon have not been defined. Patients also were stratified into those with high versus low contraction numbers and MI in each region such that roughly half were in each group to relate symptoms to contractility.
| Symptom assessment
Symptoms were quantified by modified Patient Assessment of Upper
Gastrointestinal Disorders Symptoms (PAGI-SYM) questionnaires enumerating 22 symptoms from 0 (no symptoms) to 5 (most severe).
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Overall gastroparesis severity was determined by the Gastroparesis
Cardinal Symptom Index (GCSI) score, which includes nine questions from the PAGI-SYM. 
| Data comparisons
Delayed scintigraphic solid gastric emptying (>10% 4-hour retention and/or >60% 2-hour retention) was compared in patients with normal versus delayed WMC GET to determine agreement between methods. Delayed SBTT and CTT were related to normal versus delayed and CTT (N = 6) were not analyzed separately due to small samples and were pooled in with normal transit groups. To gain insight into CUNV pathogenesis, GET, SBTT, and CTT results were compared in patients with normal versus delayed solid scintigraphy. Gastric, small bowel, and colon contraction numbers and MI were contrasted with normal and delayed solid scintigraphy to ascertain whether CUNV presents with specific contractility profiles.
Overall GCSI scores, PAGI-SYM subscores, and individual PAGI-SYM lower GI symptoms were compared in those with delayed versus normal GET, SBTT, and CTT and with high versus low numbers of contractions and MI in the hour before and after GET and during the period of colon transit.
| Statistical analyses
Exploratory data analyses using means, medians, standard deviation, Transit determinations for the whole group included patients with diabetic, idiopathic, and postfundoplication etiologies.
| RESULTS
| Transit and contractility abnormalities
Delayed solid (4-hour retention) and liquid (1-hour retention) scintigraphic gastric emptying were observed in 68.8% and 34.8% of patients, respectively ( Gastric motility index (MI) 11.5 (10.3, 12.6) 11.6 (10.4, 12.6) 11.5 (9.9, 12.6 Small bowel motility index (MI) 12.7 (11.4, 13.8) 12.9 (11.8, 14.4) 12.6 (11.1, 13.5 
| Relation of scintigraphy and WMC measures to etiology
Subgroup analyses relating to etiology focused on comparisons between diabetic versus idiopathic patients and excluded the small number of postfundoplication patients. Solid scintigraphic gastric retention was greater in diabetic versus idiopathic patients (P = .04);
liquid emptying was not different between etiologies (Figure 2A ,B).
Diabetics had longer WMC GETs ( Figure 2C ) (P = .02), and more diabetics exhibited delayed GETs (P = .01) vs idiopathic patients (P = .01) ( Table 1) . Overall agreement between 4-hour scintigraphic retention and GET in diabetics was 57.6% with a kappa of 0.14 (95% CI 0.0, 0.36), while agreement in idiopathic patients was 49.2% with a kappa of 0.09 (95% CI 0.0, 0.22). Agreements were not significantly different between etiologies (P = .64). Conversely, SBTTs were longer in idiopathic patients (P = .01). No other WMC transit or contractility measure related to etiology (Table 1 ).
| Relation of gastric emptying to other measures
Scintigraphic solid gastric retention was greater in patients with delayed (N = 118) vs normal (N = 76) GET (P = .001) ( Figure 3A ). Liquid scintigraphic retention also was higher with delayed GET (P = .02) ( Figure 3B ). Percentages of patients with solid scintigraphic delays trended higher with delayed versus normal GET (P = .08); percentages with severely delayed solid emptying were greater with delayed GET (P = .007) ( Table 2 ). Percentages of patients with delayed liquid scintigraphy were similar with delayed and normal GET.
SBTT and CTT values were similar in patients with delayed (N = 53)
vs normal (N = 110) GET (Figures 3C,D) . SBTT delays (P = .04) but not CTT delays were more prevalent among those with GET delays ( Table 2) .
Numbers of gastric contractions in the hour before capsule emptying were lower with delayed GET (P = .02) and percentages of patients with low contraction numbers were higher with delayed versus normal GET (P = .0003) ( Table 2 ). Gastric MIs in the hour before capsule emptying were lower with delayed GET (P = .0004), and percentages with low MI were greater with delayed versus normal GET (P = .01).
Numbers of colon contractions/hour were lower with delayed GET (P = .02). Numbers of small bowel contractions and MI and percentages with reductions in small bowel contractions and MI were not different with delayed versus normal GET.
GET, SBT, and CTT values and percentages of patients with re-
gional WMC delays were similar with delayed versus normal scintigraphic emptying (Table 3) . Numbers of gastric, small bowel, and colon contractions and MI and percentages with reductions in contractions and MI in the three regions were not different with delayed versus normal scintigraphy (Table 3) .
| Relation of regional transit and contractility to symptoms
Overall GCSI and PAGI-SYM subscale scores for nausea/vomiting, early satiety/postprandial fullness, bloating/visible distention, and upper and lower abdominal pain/discomfort were not different with delayed versus normal GET, SBTT, and CTT ( Figure 4A -C).
Constipation scores were higher in patients with delayed CTT (P = .03); diarrhea scores were lower in patients with delayed SBTT (P = .04) and with delayed CTT (P = .01) ( Figure 4D-F) .
PAGI-SYM upper abdominal pain/discomfort subscale scores were greater in patients with higher versus lower numbers of colon contractions (P = .03) ( Table 4) . Overall GCSI scores and nausea/vomiting, early satiety/postprandial fullness, and bloating/distention subscale scores were not different in relation to any contractility measure.
Lower abdominal pain/discomfort subscale (P = .02) and constipation scores (P = .03) were greater in those with higher vs lower colon contraction numbers. 
| DISCUSSION
This investigation is the largest, most comprehensive prospective analysis of gastric plus extragastric transit abnormalities in suspected gastroparesis using WMC methods. Although WMCs are employed much less often than scintigraphy to measure gastric emptying, our sample size compared favorably to many large published studies using gastric scintigraphy. [27] [28] [29] Additional strengths of this study included its multicenter structure with recruitment of well characterized patients, its separate analyses of diabetic versus idiopathic etiologies, its standardized analyses of diverse transit and contractility measures, and its association of motor findings to symptom profiles using validated surveys.
As in the initial study comparing scintigraphic and WMC findings in patients with prior diagnoses of gastroparesis, solid-phase gastric emptying measured by scintigraphy correlated with WMC GETs in Gastric motility index (MI) 11.7 (10.7, 12.7) 10.6 (8.7, 11.9) .0004
Reduced gastric MI (<9. Small bowel motility index (MI) 12.7 (11.6, 13.8) 12.6 (11.3, 14.0 between WMC and scintigraphic gastric emptying measures and a lower prevalence of emptying delays with WMC versus nuclear medicine tests. In the original report, correlations were stronger (R = 0.73) and WMCs detected 21% more delays than scintigraphy. 5 There are several potential explanations for these differences between the two studies. Most importantly, WMC and scintigraphic tests were performed on separate days in the current investigation while they were concurrent in the initial investigation. Coefficients of variability of up to 31% are seen on serial gastric emptying measurements regardless of the method of testing, suggesting that emptying rates are inconsistent from day to day in health and in gastroparesis. 4, 5, 30 Thus, much of the disparity between our investigation and the Kuo study may relate to different day testing. Secondly, it is established that gastric emptying of digestible solids like the egg substitute meals ingested during scintigraphy is mediated by different mechanisms (ie, fed motor pattern) than for indigestible solids like the WMC (fasting migrating motor complexes). 31, 32 This raises the possibility that emptying rates measured by the two techniques may be inherently different. Thirdly, although the caloric composition of the nutrient bars ingested during WMC testing in this study is similar to the egg substitute meals consumed with scintigraphy, subtle differences in emptying profiles have been reported for the two meals. 23 However, the magnitude of the difference in gastric emptying rates between the two meals is likely too small to explain the disparate observations of the current study and the original report. This discrepancy will be addressed by ongoing multicenter studies comparing the two techniques when performed simultaneously in patients believed to have gastroparesis. These large, prospective investigations will definitively determine whether stratification of patients into those with and without delayed gastric emptying is substantially different with the two methods.
We also confirmed extragastric WMC transit delays previously documented in studies employing less rigorous patient characterizations. 13, 14 Small bowel and colon delays were found in >40% of patients with suspected gastroparesis, and more than 20% exhibited generalized impairments. SBTT delays were associated with GET delays suggesting possible common motor impairments across gut regions but did not correlate with gastric scintigraphy delays. This finding is consistent with the different physiology of indigestible versus digestible solid emptying. 31, 32 A novel finding of our study was its characterization of rapid transit in different regions in small numbers of patients with suspected gastroparesis. 23 Others have observed rapid gastric emptying in up to 41% patients with dyspepsia using
Measure Normal 4-h scintigraphy Median (IQR) or N (%) Delayed 4-h scintigraphy Median (IQR) or N (%) P value
Transit measures
WMC GET (h) 4.0 (3.0, 14.8) 4.6 (3.2, 14.9) .36
Delayed WMC GET (>5 h) 18/60 (30.0%) 58/132 (44.0%) .09
WMC SBTT (h) 4.12 (3.23, 5.43) 3.97 (3.15, 5.37) . 49 Delayed WMC SBTT (>6 h) 9/49 (18.4%) 16/114 (14.0%) .48
WMC CTT (h) 38.7 (19.6, 74.0) 41.9 (21.9, 65.0) .65 Gastric motility index (MI) 11.5 (10.7, 12.5) 11.4 (9.9, 12.6 scintigraphy, but none have examined rapid WMC transit. 33, 34 In this investigation, rapid transit was found in too few patients (5%) for subgroup analyses.
Novel regional contractility findings were acquired from our WMC pressure data. The association of delayed GET with reduced gastric but not small bowel contractions contrasts with an earlier study in which small bowel and gastric contractility were decreased only with GET >12 hours. 16 However, that investigation only included 8 patients with mildly delayed GET (<12 hours) and was too small to be definitive.
Decreases in colon contractions related to delayed GET but not scintigraphic gastric emptying. Similarly, reduced numbers of colon contractions were noted in diabetics with delayed GET in post hoc analyses of the original WMC investigation, supportive of diffuse dysfunction in some patients with gastroparesis symptoms. 5, 17 The present study extended these findings to idiopathic patients. The preservation of normal small bowel contractions and MI in those with delayed GET suggests this gut region is less susceptible to disruption in patients with generalized dysmotility.
Our large sample allowed us to contrast transit and contractility in idiopathic disease versus diabetes. Prior studies showed no gastric scintigraphy differences between etiologies, but we found more severe emptying delays in diabetics versus idiopathic patients using both
WMCs and scintigraphy. 9 However, device agreements between scintigraphy and WMCs were similar in diabetic and idiopathic patients.
Furthermore, SBTTs were shorter in diabetics than in idiopathic patients. Physiologic studies have noted differences in gastric pH and pancreatic polypeptide release in diabetic versus idiopathic gastroparesis suggesting more severe vagal impairments with diabetes.
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Our findings support differential pathogenesis of transit impairments in relation to etiology, perhaps secondary to different degrees of vagal dysfunction.
The comprehensive associations of symptoms with transit and contractility included in this study complement detailed published observations by the Gastroparesis Consortium relating symptoms to scintigraphic gastric emptying. 18 Gastroparesis symptoms showed little correlation with GETs or other WMC transit or contractility measures; only numbers of colon contractions positively associated with upper abdominal pain severity. These findings suggest symptoms of gastroparesis are not solely determined by gastric, small intestinal, or colon transit. Furthermore, these observations are at odds with a prior smaller study reporting higher global gastroparesis symptoms with reduced small bowel contractions. 19 Individual symptoms were not examined in that previous investigation. Similarly, another study employing dichotomous symptom assessments found no symptom correlation with WMC measures.
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This investigation raises new questions about CUNV pathogenesis. We hypothesized that WMC testing would uncover distinct extragastric transit or contractile profiles in patients with normal gastric scintigraphy given the symptom overlaps of gastroparesis and the lower functional bowel disorders. 8, 9 However, no WMC small bowel or colon transit or contractility abnormalities were specific for those with normal scintigraphy suggesting that no regional transit or phasic motor pattern is definitive for symptom genesis in CUNV. These findings warrant consideration of other pathophysiologic contributors including impaired gastric accommodation, altered luminal sensation, myoelectric dysfunction, or central nervous system abnormalities not detectable by gastric emptying testing as causes of CUNV pathogenesis.
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Our analyses associated lower GI symptoms in patients with suspected gastroparesis to WMC transit and contractility. In contrast to gastroparesis symptoms, diarrhea related to rapid SBTT and CTT while constipation scores were higher in those with delayed CTT and increased colon contractions and lower abdominal pain correlated with higher colon contractility. These findings parallel a prior WMC study, in which patients with constipation-predominant irritable bowel syndrome showed greater contractility than those with functional constipation. 24 This investigation had limitations. Although most agents affecting transit were discontinued for study conduct, some maintenance medications (eg antihypertensives, antidepressants) might have influenced WMC measures. Because patients returned data recorders 4-7 days after WMC ingestion, definitive CTT determination was not possible in some individuals. However, in more than two-thirds of these patients, we were still able to diagnose delayed CTT. It would have been impractical to lengthen the data collection period to define CTT in the remainder. Glycemic control was not monitored in diabetics; thus, acute hyperglycemic effects on transit or contractility cannot be excluded. 40 Despite drawbacks, these important findings provide a foundation for additional investigations defining impacts of WMC performance on patient management.
As with other methods of emptying testing including scintigraphy, there are few published studies which objectively demonstrate that quantifying the rate of gastric emptying influences any symptom or resource utilization outcome in suspected gastroparesis. However in one investigation, scintigraphic gastric retention >20% was associated with superior outcomes versus milder impairments supporting the utility of emptying testing. 41 Future studies will define whether WMC testing leads to different treatment decisions versus scintigraphy. Further, it is uncertain whether treating small bowel or colon transit or contractility abnormalities detected by WMC testing has additional impact on patient outcomes. In an uncontrolled pediatric study, osmotic laxatives reduced gastric emptying delays and improved dyspeptic symptoms in children with functional dyspepsia. 42 Larger controlled trials could validate the concept that gastroparesis improves with treatments targeting distal gut dysfunction.
In conclusion, WMCs define similar but not identical gastric emptying delays as scintigraphy which are more severe in diabetics and correlate with reduced gastric and colon contractility. Extragastric or generalized transit delays occur in >40% of patients with gastroparesis symptoms. Upper GI symptoms correlate poorly with WMC defects and do not distinguish gastroparesis from CUNV, although lower GI symptoms associate with transit and contractility abnormalities. These findings provide insight into gastroparesis pathogenesis and form a basis for future investigations studying the impact of WMC testing on clinical care.
